CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-29 | Cohen Steven Michael Director | Grant or award · Restricted Stock Units | +431,034 | 431,034 | ||
| 2025-07-29 | Herhalt Johann Michael Director | Grant or award · Restricted Stock Units | +431,034 | 431,034 | ||
| 2025-07-29 | Looney Thomas P. Director | Grant or award · Restricted Stock Units | +431,034 | 431,034 | ||
| 2025-07-29 | Hopkinson David G. Director | Grant or award · Restricted Stock Units | +431,034 | 431,034 | ||
| 2025-07-29 | Clanachan David F Director | Grant or award · Restricted Stock Units | +431,034 | 431,034 | ||
| 2025-07-29 | Persofsky Renah Director | Grant or award · Restricted Stock Units | +431,034 | 431,034 | ||
| 2025-07-29 | Gendel Mitchell Global General Counsel | Grant or award · Restricted Stock Units | +1,748,793 | 1,748,793 | ||
| 2025-07-29 | Merton Carl A Chief Financial Officer | Grant or award · Restricted Stock Units | +1,208,339 | 1,208,339 | ||
| 2025-07-29 | SIMON IRWIN D President and CEO | Grant or award · Restricted Stock Units | +8,568,966 | 8,568,966 | ||
| 2025-06-02 | SIMON IRWIN D President and CEO | Option exercise | +1,178,109 | $0.41 | $483K | 4,424,593 |
| 2025-06-02 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −647,960 | $0.41 | $266K | 3,776,633 |
| 2025-06-02 | SIMON IRWIN D President and CEO | Returned to the company · Restricted Stock Units ("LTIP RSUs") | −1,178,109 | 0 | ||
| 2025-06-02 | Merton Carl A Chief Financial Officer | Option exercise | +174,477 | $0.41 | $72K | 860,532 |
| 2025-06-02 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −95,963 | $0.41 | $39K | 764,569 |
| 2025-06-02 | Merton Carl A Chief Financial Officer | Returned to the company · Restricted Stock Units ("LTIP RSUs") | −174,477 | 0 | ||
| 2025-06-02 | Gendel Mitchell Global General Counsel | Option exercise | +231,218 | $0.41 | $95K | 651,486 |
| 2025-06-02 | Gendel Mitchell Global General Counsel | Shares withheld for taxes | −117,922 | $0.41 | $48K | 533,564 |
| 2025-06-02 | Gendel Mitchell Global General Counsel | Returned to the company · Restricted Stock Units ("LTIP RSUs") | −231,218 | 0 | ||
| 2025-06-02 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +249,353 | $0.41 | $102K | 785,046 |
| 2025-06-02 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −127,171 | $0.41 | $52K | 657,875 |
Page 7 of 35 · 686 trades